Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone applied in the middle ear during stapedotomy for otosclerosis
IRCT20220111053690N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexamethasone in otosclerosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: High-frequency audiometry and Full-frequency audiometry. Started Apr 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
otosclerosis
Beyond the preview
Go deeper on IRCT20220111053690N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220111053690N1.